Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Nature Methods|February 24, 2023
Outbreak.info Research Library: a standardized, searchable platform to discover and explore COVID-19 resourcesGinger Tsueng, Julia L Mullen, Manar Alkuzweny, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2022
Outbreak.info Research Library: A standardized, searchable platform to discover and explore COVID-19 resourcesGinger Tsueng, Julia L Mullen, Manar Alkuzweny, et al.
Plos One|September 23, 2024
Matrix metalloproteinases mediate influenza A-associated shedding of the alveolar epithelial glycocalyxKaitlyn R Schaaf, Stuart R Landstreet, Nathan D Putz, et al.
Cancer Research Communications|March 30, 2026
Genomic and transcriptomic analysis of high-grade endometrial carcinoma reveals biological heterogeneity and molecular classification challengesMasahito Kawazu, Ayumi Taguchi, Emiko Yoshida, et al.
Msystems|December 31, 2025
The NIAID Discovery Portal: a unified search engine for infectious and immune-mediated disease datasetsGinger Tsueng, Emily Bullen, Candice Czech, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
Tumor cell death by ferroptosis contributes to an immunosuppressive tumor microenvironment in syngeneic murine models of cancerNneka E Mbah, Damien Sutton, Hanna S Hong, et al.
Eclinicalmedicine|September 23, 2024
Upfront or delayed surgery in resectable hepatoblastoma: analysis from the children's hepatic tumors international collaboration databaseEiso Hiyama, Tomoro Hishiki, Kenichi Yoshimura, et al.
Science Immunology|November 18, 2022
OXPHOS promotes apoptotic resistance and cellular persistence in T<sub>H</sub>17 cells in the periphery and tumor microenvironmentHanna S Hong, Nneka E Mbah, Mengrou Shan, et al.
JHEP Reports : Innovation in Hepatology|December 9, 2025
The efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytesHiroaki Kanzaki, Takamasa Ishino, Sadahisa Ogasawara, et al.
Cancer Research Communications|March 16, 2023
Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune InfiltrationTakao Morinaga, Takashi Inozume, Masahito Kawazu, et al.
Pageof 13